CATEGORIES

© Copyright 2004; Hanoitimes - Economic and Urban Newspaper;

The tribune of Hanoi People’s Committee

Publication Permit: 29/GP-CBC

Editor - in - Chief: Nguyen Thanh Loi

Managing Editor: Ta Thu Giang

Email : thugiang@hanoitimes.vn

Head Office: 21 Huynh Thuc Khang Street, Dong Da District, Hanoi

Branch Office: 221 Tran Phu Street, Ha Dong District, Hanoi

WORDS ON THE STREET 70th anniversary of Hanoi's Liberation Day Vietnam - Asia 2023 Smart City Summit Hanoi celebrates 15 years of administrative boundary adjustment 12th Vietnam-France decentrialized cooperation conference 31st Sea Games - Vietnam 2021 Covid-19 Pandemic
Home / Investment / News
Japan's Taisho Group offers to buy extra 7.06% stake in DHG Pharmaceutical
Ngoc Thuy 12:35, 2018/07/06
The deal is expected to cost the Japanese pharmaceutical company VND1.1 trillion (US$47.68 million).
Japan-based Taisho Group has announced its intention to purchase another 7.06% stake of DHG Pharmaceutical JSC (DHG) in a public offer at a price of VND120,000 (US$5.20) apiece, 20% higher than the market price of VND99,900 (US$4.34) at the close on July 4, DHG said in a filing to the Ho Chi Minh City Stock Exchange (HOSE). 
 
Illustration photo.
Illustration photo.
At such price, Taisho Group is expected to spend nearly VND1.1 trillion (US$47.68 million) in exchange for 9.2 million shares of Hau Giang Pharmaceutical. 

Once the deal is completed, Taisho Group will increase its holding in the Vietnamese firm to 32% or over 41.83 million shares. The proposed time to realize this public offer is within 30 to 60 days after receiving the written approval from the State Securities Commission of Vietnam (SSC) on the public offer. 

The Japanese group in early June spent VND85.5 billion (US$3.71 million) for 650,000 shares of DHG, raising its holding in the Vietnamese medicine producer to 24.94%. 

Over the past month, DHG shares have lost 13% in value. However, since its listing, the company's share value increased a whooping of 459% to VND99,900 (US$4.34) per share at the close on July 4. 

The shares then increased by 5.31% to VND105,200 (US$4.57) apiece at the close of July 5. 

On July 4, DHG Pharmaceutical's foreign ownership limit was removed, as a result, the company adjusted its strategic targets for period 2018 - 2020 to a minimum increase of revenue at 13% and pre-tax profit of at least 7%. 
Comments
Other news
14:43, 2024/11/18
Aircraft manufacturer Embraer seeks comprehensive aviation partnership with Vietnam
The Vietnamese leader urges the aircraft manufacturer to collaborate on technology transfer, airport construction and operation, research, and investment in Vietnam.
21:55, 2024/10/22
Better links with FDI firms to support Hanoi businesses
Hanoi will continue to focus on quality projects, especially with partners such as Japan, the United States, and Europe to boost technology transfer.
15:24, 2024/09/24
Vietnam calls for more US investment in innovation, hi-tech
The Vietnamese leader called on relevant agencies to resolve any challenges faced by investors and enhance the investment climate to encourage greater US investment in Vietnam.
14:13, 2024/09/23
Vietnamese leader urges Boeing to build production facility in Vietnam
Boeing is committed to continuing to support the development of Vietnam's aviation ecosystem, focusing on aviation infrastructure, human resources training, airport construction, and aircraft maintenance facilities.
14:38, 2024/09/17
Foreign capital pouring into Vietnam's real estate market
Experts are optimistic that the 2024 Land Law, once enacted, will help resolve legal bottlenecks and attract more FDI.
16:27, 2024/08/24
Vietnam news in brief - August 24
Read The Hanoi Times to stay up to date on developments in Vietnam.